ReferencesPackage Insert: Updated 03/2016
https://www.avonex.com/content/dam/commercial/multiple-sclerosis/avonex/pat/en_us/pdf/Avonex%20US%20%20Prescribing%20Information.pdf
1. Oliver BJ, Kohli E, Kasper LH. Interferon therapy in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of the comparative trials. J Neurol Sci. 2011 Mar 15;302(1-2):96-105. http://www.ncbi.nlm.nih.gov/entrez/q..._uids=21167504
2. Markowitz C. Development of interferon-beta as a therapy for multiple sclerosis. Expert Opin Emerg Drugs. 2004 Nov;9(2):363-374. http://www.ncbi.nlm.nih.gov/pubmed/15571491?dopt=Citation
3. Rudick RA, Goodkin DE, Jacobs LD, Cookfair DL, Herndon RM, Richert JR, et al. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology. 1997 Aug;49(2):358-363. http://www.ncbi.nlm.nih.gov/pubmed/9270562?dopt=Citation
4. Jacobs L, Brownscheidle CM. Appropriate use of interferon beta-1a in multiple sclerosis. BioDrugs. 1999 Mar;11(3):155-163. http://www.ncbi.nlm.nih.gov/pubmed/18031126?dopt=Citation
5. Annibali V1, Mechelli R1, Romano S1, Buscarinu MC1, Fornasiero A1, Umeton R1 et al. IFN-β and multiple sclerosis: From etiology to therapy and back. Cytokine Growth Factor Rev. 2014 Oct 31. pii: S1359-6101(14)00138-5. http://www.ncbi.nlm.nih.gov/pubmed/25466632
6. Gohil K. Pharmaceutical approval update. P T. 2014 Oct;39(10):684-94. http://www.ncbi.nlm.nih.gov/pubmed/25336862
7. Tao Y, Zhang X, Zivadinov R, Dwyer MG, Kennedy C et al. Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2015 Nov 12;2(6):e176. http://www.ncbi.nlm.nih.gov/pubmed/26601116
8. Gerischer LM, Siebert E, Janke O, Jungehuelsing GJ, Ruprecht K. Favorable outcome of interferon-beta associated thrombotic microangiopathy following treatment with corticosteroids, plasma exchange and rituximab: A case report. Mult Scler Relat Disord. 2016 Nov;10:63-65
9. Einarson TR, Bereza BG, Machado M. Comparative effectiveness of interferons in relapsing-remitting multiple sclerosis: a meta-analysis of real-world studies. Curr Med Res Opin. 2017 Jan 11:1-15. https://www.ncbi.nlm.nih.gov/pubmed/28027680